These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29563117)

  • 21. Antiplatelet medications: old and emerging therapies.
    Stone WM; Naidu SG; Chapital A; Money SR
    Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelets unplugged: an ATVB special series focused on platelet biology.
    Smyth SS
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2339-40. PubMed ID: 21084705
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent Insights Into the Regulation of Coagulation and Thrombosis.
    Li X; Sim MMS; Wood JP
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):e119-e125. PubMed ID: 32320291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapeutic approaches to combat arterial thrombosis: better drugs for old targets, novel targets, and future prospects.
    Choi J; Kermode JC
    Mol Interv; 2011 Apr; 11(2):111-23. PubMed ID: 21540471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory mechanisms of cAMP levels as a multiple target for antiplatelet activity and less bleeding risk.
    Fuentes E; Palomo I
    Thromb Res; 2014 Aug; 134(2):221-6. PubMed ID: 24830902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New anti-platelet agents: the end of resistance?
    Kastrati A
    Thromb Res; 2012 Oct; 130 Suppl 1():S53-5. PubMed ID: 23026663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet dysfunction in central obesity.
    Anfossi G; Russo I; Trovati M
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):440-9. PubMed ID: 19346117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications.
    Luo BY; Jiang JL; Fang YF; Yang F; Yin MD; Zhang BC; Zhao RR; Shao JW
    Pharmacol Res; 2020 Sep; 159():105031. PubMed ID: 32562816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
    Nurden AT
    Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A brief review on high on-aspirin residual platelet reactivity.
    Pettersen AA; Arnesen H; Seljeflot I
    Vascul Pharmacol; 2015; 67-69():6-9. PubMed ID: 25869498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet oxidative stress as a novel target of cardiovascular risk in frail older people.
    Fuentes F; Palomo I; Fuentes E
    Vascul Pharmacol; 2017 Aug; 93-95():14-19. PubMed ID: 28705733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
    Lippi G; Franchini M; Targher G
    Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
    [No Abstract]   [Full Text] [Related]  

  • 35. A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation.
    Mischnik M; Boyanova D; Hubertus K; Geiger J; Philippi N; Dittrich M; Wangorsch G; Timmer J; Dandekar T
    Mol Biosyst; 2013 Jun; 9(6):1326-39. PubMed ID: 23463387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function tests: a comparative review.
    Paniccia R; Priora R; Liotta AA; Abbate R
    Vasc Health Risk Manag; 2015; 11():133-48. PubMed ID: 25733843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet agents: current drugs and future trends.
    Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editors' Choice papers in Thrombosis and Haemostasis.
    Weber C; Lip GY
    Thromb Haemost; 2015 Jan; 113(1):217-20. PubMed ID: 25567474
    [No Abstract]   [Full Text] [Related]  

  • 40. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
    Cattaneo M
    Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.